Clinical trial

PTC Guiding Neoadjuvant Treatment in Breast Cancer

NCT05103293

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2021-11-01

PhasePHASE2

Study timeline

Study start (actual)2021-11-01Date precision: day

Registry last updated2023-12-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pathological Conditions, Signs and Symptomsunresolved

Interventions

patient-derived tumor-like cell clusters drug sensitivity testDIAGNOSTIC_TEST

Sponsors & collaborators

Zhejiang Cancer Hospitallead sponsor

Mapped research locations

HangzhouZhejiang, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05103293 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.